Haemonetics (HAE) Raw Materials (2011)

Haemonetics (HAE) posted Raw Materials of $35.3 million for Q4 2011, up 16.35% on a QoQ basis from $30.4 million in Q3 2011.

Analysis

Haemonetics (HAE) Raw Materials (2011) Analysis & Trends

Haemonetics has reported Raw Materials for 1 years, with the latest figure at $35.3 million in Q4 2011.

On a quarterly basis, Raw Materials changed N/A year-over-year to $35.3 million in Q4 2011; TTM through Oct 2011 was $35.3 million, a N/A change from a year earlier, with the FY2011 full-year figure at $26.4 million, changed N/A from the prior year.
Raw Materials was $35.3 million for Q4 2011 at Haemonetics, up from $30.4 million in the prior quarter.
The five-year high for Raw Materials was $35.3 million in Q4 2011, with the low at $26.4 million in Q2 2011.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	180.08 Bn	174.48 Bn	7.27 Bn
2	Intuitive Surgical	127.86 Bn	122.64 Bn	1.96 Bn
3	Medtronic	117.15 Bn	108.33 Bn	6.34 Bn
4	Stryker	103.82 Bn	100.34 Bn	4.50 Bn
5	Boston Scientific	63.24 Bn	62.70 Bn	3.85 Bn
6	Edwards Lifesciences	49.76 Bn	45.51 Bn	1.35 Bn
7	Alcon	32.95 Bn	31.49 Bn	1.68 Bn
8	Dexcom	32.22 Bn	30.27 Bn	830.00 Mn
9	Steris	20.71 Bn	20.23 Bn	684.20 Mn
10	Haemonetics	4.58 Bn	4.36 Bn	202.80 Mn

Historic Data

Download Data